Biovica International AB (publ) (STO:BIOVIC.B)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.2950
-0.0010 (-0.34%)
Oct 14, 2026, 4:39 PM CET

Biovica International AB Revenue

Biovica International AB had revenue of 3.92M SEK in the quarter ending July 31, 2026, with 39.60% growth. This brings the company's revenue in the last twelve months to 16.21M, up 43.27% year-over-year. In the fiscal year ending April 30, 2026, Biovica International AB had annual revenue of 15.10M with 37.76% growth. That makes Biovica International AB the 42,925th largest company in the world by revenue and 646th in Sweden.

Revenue (ttm)
16.21M
Revenue Growth
+43.27%
P/S Ratio
5.77
Revenue / Employee
622.21K
Employees
24
Market Cap
86.11M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Apr 30, 202615.10M4.14M37.76%
Apr 30, 202510.96M2.66M32.00%
Apr 30, 20248.30M2.61M45.79%
Apr 30, 20235.70M-601.00K-9.55%
Apr 30, 20226.30M-2.58M-29.08%
Apr 30, 20218.88M-1.04M-10.51%
Apr 30, 20209.92M-523.00K-5.01%
Apr 30, 201910.44M499.00K5.02%
Apr 30, 20189.95M4.37M78.45%
Apr 30, 20175.57M-3.08M-35.60%
Apr 30, 20168.65M3.64M72.73%
Apr 30, 20155.01M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Nanologica AB129.48M
NextCell Pharma AB10.78M
AcouSort AB9.31M
OncoZenge AB5.97M
Spago Nanomedical AB3.81M
Pila Pharma AB275.74K
Revenue Rankings